• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大麻素1受体下游偏向性β-抑制蛋白介导信号传导的机制

Mechanisms of Biased β-Arrestin-Mediated Signaling Downstream from the Cannabinoid 1 Receptor.

作者信息

Delgado-Peraza Francheska, Ahn Kwang H, Nogueras-Ortiz Carlos, Mungrue Imran N, Mackie Ken, Kendall Debra A, Yudowski Guillermo A

机构信息

Department of Anatomy and Neurobiology (F.D.-P., G.A.Y.) and Institute of Neurobiology (F.D.-P., C.N.-O., G.A.Y.), University of Puerto Rico - Medical Sciences Campus, San Juan, Puerto Rico; Department of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut (K.H.A., D.A.K.); Department of Pharmacology & Experimental Therapeutics, Louisiana State University Health Sciences Center, New Orleans, Louisiana (I.N.M.); and Department of Psychological & Brain Sciences, Gill Center for Biomedical Sciences, Indiana University, Bloomington, Indiana (K.M.).

Department of Anatomy and Neurobiology (F.D.-P., G.A.Y.) and Institute of Neurobiology (F.D.-P., C.N.-O., G.A.Y.), University of Puerto Rico - Medical Sciences Campus, San Juan, Puerto Rico; Department of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut (K.H.A., D.A.K.); Department of Pharmacology & Experimental Therapeutics, Louisiana State University Health Sciences Center, New Orleans, Louisiana (I.N.M.); and Department of Psychological & Brain Sciences, Gill Center for Biomedical Sciences, Indiana University, Bloomington, Indiana (K.M.)

出版信息

Mol Pharmacol. 2016 Jun;89(6):618-29. doi: 10.1124/mol.115.103176. Epub 2016 Mar 23.

DOI:10.1124/mol.115.103176
PMID:27009233
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4885504/
Abstract

Activation of G protein-coupled receptors results in multiple waves of signaling that are mediated by heterotrimeric G proteins and the scaffolding proteins β-arrestin 1/2. Ligands can elicit full or subsets of cellular responses, a concept defined as ligand bias or functional selectivity. However, our current understanding of β-arrestin-mediated signaling is still very limited. Here we provide a comprehensive view of β-arrestin-mediated signaling from the cannabinoid 1 receptor (CB1R). By using a signaling biased receptor, we define the cascades, specific receptor kinases, and molecular mechanism underlying β-arrestin-mediated signaling: We identify the interaction kinetics of CB1R and β-arrestin 1 during their endocytic trafficking as directly proportional to its efficacy. Finally, we demonstrate that signaling results in the control of genes clustered around prosurvival and proapoptotic functions among others. Together, these studies constitute a comprehensive description of β-arrestin-mediated signaling from CB1Rs and suggest modulation of receptor endocytic trafficking as a therapeutic approach to control β-arrestin-mediated signaling.

摘要

G蛋白偶联受体的激活会引发多波信号传导,这些信号由异源三聚体G蛋白和支架蛋白β-抑制蛋白1/2介导。配体可引发细胞反应的全部或部分反应,这一概念被定义为配体偏向性或功能选择性。然而,我们目前对β-抑制蛋白介导的信号传导的理解仍然非常有限。在此,我们提供了大麻素1受体(CB1R)介导的β-抑制蛋白信号传导的全面观点。通过使用一种信号偏向性受体,我们定义了β-抑制蛋白介导的信号传导的级联反应、特定受体激酶和分子机制:我们确定了CB1R与β-抑制蛋白1在其胞吞运输过程中的相互作用动力学与其效力成正比。最后,我们证明信号传导可控制包括促生存和促凋亡功能等在内的相关基因。总之,这些研究构成了对CB1R介导的β-抑制蛋白信号传导的全面描述,并表明调节受体内吞运输作为控制β-抑制蛋白介导的信号传导的一种治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a615/4885504/cf997da1dd4f/mol.115.103176f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a615/4885504/bdc4ed4d0f8d/mol.115.103176f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a615/4885504/f236f14a0b7d/mol.115.103176f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a615/4885504/7c55c3adfaea/mol.115.103176f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a615/4885504/f75e94049f1c/mol.115.103176f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a615/4885504/b7b802dbffe1/mol.115.103176f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a615/4885504/53a8893183e4/mol.115.103176f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a615/4885504/cf997da1dd4f/mol.115.103176f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a615/4885504/bdc4ed4d0f8d/mol.115.103176f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a615/4885504/f236f14a0b7d/mol.115.103176f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a615/4885504/7c55c3adfaea/mol.115.103176f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a615/4885504/f75e94049f1c/mol.115.103176f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a615/4885504/b7b802dbffe1/mol.115.103176f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a615/4885504/53a8893183e4/mol.115.103176f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a615/4885504/cf997da1dd4f/mol.115.103176f7.jpg

相似文献

1
Mechanisms of Biased β-Arrestin-Mediated Signaling Downstream from the Cannabinoid 1 Receptor.大麻素1受体下游偏向性β-抑制蛋白介导信号传导的机制
Mol Pharmacol. 2016 Jun;89(6):618-29. doi: 10.1124/mol.115.103176. Epub 2016 Mar 23.
2
Ligand-specific endocytic dwell times control functional selectivity of the cannabinoid receptor 1.配体特异性内吞停留时间控制大麻素受体1的功能选择性。
Nat Commun. 2014 Aug 1;5:4589. doi: 10.1038/ncomms5589.
3
Type 1 cannabinoid receptor ligands display functional selectivity in a cell culture model of striatal medium spiny projection neurons.1 型大麻素受体配体在纹状体中间棘突投射神经元的细胞培养模型中表现出功能选择性。
J Biol Chem. 2014 Sep 5;289(36):24845-62. doi: 10.1074/jbc.M114.557025. Epub 2014 Jul 18.
4
Distinct roles of β-arrestin 1 and β-arrestin 2 in ORG27569-induced biased signaling and internalization of the cannabinoid receptor 1 (CB1).β-arrestin1 和 β-arrestin2 在 ORG27569 诱导的大麻素受体 1 (CB1) 偏置信号和内化中的不同作用。
J Biol Chem. 2013 Apr 5;288(14):9790-9800. doi: 10.1074/jbc.M112.438804. Epub 2013 Feb 28.
5
CB(1) receptor allosteric modulators display both agonist and signaling pathway specificity.CB(1) 受体别构调节剂表现出激动剂和信号通路特异性。
Mol Pharmacol. 2013 Feb;83(2):322-38. doi: 10.1124/mol.112.080879. Epub 2012 Nov 15.
6
Pharmacological characterization of receptor redistribution and beta-arrestin recruitment assays for the cannabinoid receptor 1.大麻素受体1的受体再分布及β-抑制蛋白募集试验的药理学特性
J Biomol Screen. 2009 Aug;14(7):811-23. doi: 10.1177/1087057109337937. Epub 2009 Jun 11.
7
Biased Agonism and Biased Allosteric Modulation at the CB1 Cannabinoid Receptor.CB1大麻素受体的偏向激动作用和偏向变构调节
Mol Pharmacol. 2015 Aug;88(2):368-79. doi: 10.1124/mol.115.099192. Epub 2015 Jun 4.
8
The Multiple Waves of Cannabinoid 1 Receptor Signaling.大麻素1受体信号传导的多波
Mol Pharmacol. 2016 Nov;90(5):620-626. doi: 10.1124/mol.116.104539. Epub 2016 Jun 23.
9
Characterization of structurally novel G protein biased CB agonists: Implications for drug development.结构新颖的 G 蛋白偏向 CB 激动剂的表征:对药物开发的影响。
Pharmacol Res. 2017 Nov;125(Pt B):161-177. doi: 10.1016/j.phrs.2017.08.008. Epub 2017 Aug 23.
10
Cannabinoid Receptor Interacting Protein 1a Competition with β-Arrestin for CB1 Receptor Binding Sites.大麻素受体相互作用蛋白1a与β-抑制蛋白竞争CB1受体结合位点。
Mol Pharmacol. 2017 Feb;91(2):75-86. doi: 10.1124/mol.116.104638. Epub 2016 Nov 28.

引用本文的文献

1
Potentiation of mitochondrial function by mitoDREADD-G reverses pharmacological and neurodegenerative cognitive impairment in mice.线粒体设计受体激动剂-G增强线粒体功能可逆转小鼠的药物性和神经退行性认知障碍。
Nat Neurosci. 2025 Aug 11. doi: 10.1038/s41593-025-02032-y.
2
Advances in cannabinoid receptors pharmacology: from receptor structural insights to ligand discovery.大麻素受体药理学进展:从受体结构洞察到配体发现
Acta Pharmacol Sin. 2025 Feb 5. doi: 10.1038/s41401-024-01472-9.
3
Comparing CB1 receptor GIRK channel responses to receptor internalization using a kinetic imaging assay.

本文引用的文献

1
Emerging Functional Divergence of β-Arrestin Isoforms in GPCR Function.β- arrestin 异构体在 GPCR 功能中出现的功能分化。
Trends Endocrinol Metab. 2015 Nov;26(11):628-642. doi: 10.1016/j.tem.2015.09.001. Epub 2015 Oct 21.
2
Targeting β-arrestin2 in the treatment of L-DOPA-induced dyskinesia in Parkinson's disease.靶向β-抑制蛋白2治疗帕金森病左旋多巴诱导的异动症
Proc Natl Acad Sci U S A. 2015 May 12;112(19):E2517-26. doi: 10.1073/pnas.1502740112. Epub 2015 Apr 27.
3
Delineation of a conserved arrestin-biased signaling repertoire in vivo.
使用动力学成像测定法比较 CB1 受体 GIRK 通道反应与受体内化。
Sci Rep. 2024 Aug 7;14(1):18314. doi: 10.1038/s41598-024-68451-2.
4
Pharmacological Evaluation of Cannabinoid Receptor Modulators Using GRAB Sensor.大麻素受体调节剂的 GRAB 传感器药理学评价
Int J Mol Sci. 2024 May 3;25(9):5012. doi: 10.3390/ijms25095012.
5
Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB receptor.评估大麻素 CB 受体上合成大麻素受体激动剂的信号转导偏倚。
Pharmacol Res Perspect. 2023 Dec;11(6):e01157. doi: 10.1002/prp2.1157.
6
SGIP1 in axons prevents internalization of desensitized CB1R and modifies its function.轴突中的SGIP1可防止脱敏的CB1R内化并改变其功能。
Front Neurosci. 2023 Jul 20;17:1213094. doi: 10.3389/fnins.2023.1213094. eCollection 2023.
7
Cannabinoid receptor type 1 (CBR) inhibits hypothalamic leptin signaling via β-arrestin1 in complex with TC-PTP and STAT3.1型大麻素受体(CBR)通过与酪氨酸磷酸酶非受体型(TC-PTP)和信号转导子与转录激活子3(STAT3)结合的β-抑制蛋白1抑制下丘脑瘦素信号传导。
iScience. 2023 Jun 25;26(7):107207. doi: 10.1016/j.isci.2023.107207. eCollection 2023 Jul 21.
8
Cannabinoid Tolerance in S426A/S430A x -Arrestin 2 Knockout Double-Mutant Mice.S426A/S430A x -Arrestin 2 敲除双突变小鼠中的大麻素耐受性。
J Pharmacol Exp Ther. 2023 Apr;385(1):17-34. doi: 10.1124/jpet.122.001367. Epub 2023 Jan 20.
9
The incidence of candidate binding sites for β-arrestin in Drosophila neuropeptide GPCRs.果蝇神经肽 GPCR 中β-arrestin 结合位点候选物的发生率。
PLoS One. 2022 Nov 1;17(11):e0275410. doi: 10.1371/journal.pone.0275410. eCollection 2022.
10
Cannabinoid 1 (CB ) receptor arrestin subtype-selectivity and phosphorylation dependence.大麻素 1(CB1)受体抑制蛋白亚型选择性和磷酸化依赖性。
Br J Pharmacol. 2023 Feb;180(3):369-382. doi: 10.1111/bph.15973. Epub 2022 Nov 6.
体内保守的视紫红质抑制蛋白偏向性信号传导谱的描绘。
Mol Pharmacol. 2015 Apr;87(4):706-17. doi: 10.1124/mol.114.095224. Epub 2015 Jan 30.
4
Imaging of kiss-and-run exocytosis of surface receptors in neuronal cultures.神经元培养物中表面受体亲吻-逃离式胞吐作用的成像
Front Cell Neurosci. 2014 Nov 3;8:363. doi: 10.3389/fncel.2014.00363. eCollection 2014.
5
Real-time imaging of mu opioid receptors by total internal reflection fluorescence microscopy.通过全内反射荧光显微镜对μ阿片受体进行实时成像。
Methods Mol Biol. 2015;1230:79-86. doi: 10.1007/978-1-4939-1708-2_6.
6
Ligand-specific endocytic dwell times control functional selectivity of the cannabinoid receptor 1.配体特异性内吞停留时间控制大麻素受体1的功能选择性。
Nat Commun. 2014 Aug 1;5:4589. doi: 10.1038/ncomms5589.
7
Type 1 cannabinoid receptor ligands display functional selectivity in a cell culture model of striatal medium spiny projection neurons.1 型大麻素受体配体在纹状体中间棘突投射神经元的细胞培养模型中表现出功能选择性。
J Biol Chem. 2014 Sep 5;289(36):24845-62. doi: 10.1074/jbc.M114.557025. Epub 2014 Jul 18.
8
Mutation of putative GRK phosphorylation sites in the cannabinoid receptor 1 (CB1R) confers resistance to cannabinoid tolerance and hypersensitivity to cannabinoids in mice.大麻素受体 1(CB1R)中假定的 GRK 磷酸化位点突变赋予小鼠对大麻素耐受性和对大麻素超敏性的抗性。
J Neurosci. 2014 Apr 9;34(15):5152-63. doi: 10.1523/JNEUROSCI.3445-12.2014.
9
GPCR signaling along the endocytic pathway.G 蛋白偶联受体沿着内吞途径的信号转导。
Curr Opin Cell Biol. 2014 Apr;27:109-16. doi: 10.1016/j.ceb.2013.10.003. Epub 2013 Dec 28.
10
Minireview: More than just a hammer: ligand "bias" and pharmaceutical discovery.综述:不止是一把锤子:配体“偏向性”与药物研发
Mol Endocrinol. 2014 Mar;28(3):281-94. doi: 10.1210/me.2013-1314. Epub 2014 Jan 16.